Study of Potential Blocking Peptides Targeting the SARS-CoV-2 RBD/hACE2 Interaction
These results demonstrate that BP2, specifically, is a promising candidate for the development of novel therapeutic interventions targeting SARS-CoV-2 and other coronaviruses that use hACE2 for cellular entry.
Authors
- Carlos Javier Alméciga-Díaz (ORCID: https://orcid.org/0000-0001-6484-1173)
- Sonia Mayra Pérez‐Tapia (ORCID: https://orcid.org/0000-0002-2818-8522)
- Ángela J. Espejo (ORCID: https://orcid.org/0000-0001-9670-6435)
- Martha Pedraza‐Escalona (ORCID: https://orcid.org/0000-0002-5838-0873)
- Jenny Andrea Arévalo-Romero
- Sara M. Villada-Troncoso
- Vanessa Hernández Rivera
Institutions
- Pontificia Universidad Javeriana (CO)
- Instituto Politécnico Nacional (MX)
Publication Details
- Journal
- Pharmaceuticals
- Published
- 2024-09-20
- DOI
- https://doi.org/10.3390/ph17091240
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pontificia Universidad Javeriana